VCA Inc.
Feb 15, 2002

VCA Antech Invites the Public to Join its Fourth Quarter & Year-End Earnings Conference Call on the Web

Los Angeles, Calif. - February 15, 2002 - VCA Antech, Inc. (NASDAQ Symbol: WOOF) announces it will hold a conference call to review results for its fourth quarter and year ended December 31, 2001. The public is invited to listen to its conference call broadcast live on the Internet on Thursday, February 21, 2002 at 4:30 p.m. ET, with Bob Antin, Chairman and Chief Executive Officer.

Financial results will be released over Business Wire after the market closes on Thursday, February 21, 2002. The press release will also be posted on VCA Antech's Investor Relations site at http://investor.vcaantech.com.

What: VCA Antech's 2001 fourth quarter & year end earnings conference call webcast
Date: February 21, 2002
Time: 4:30 p.m. ET
Two ways to join: 1) Live over the Internet - Simply log-on to the web to http://investor.vcaantech.com. (Minimum requirements to listen to the broadcast: Real Player or Windows Media Player software and at least 14.4Kbps connection to the Internet. Use the link above to pre-test existing capabilities and to download the free software if needed.) Web replay will be available beginning February 22, 2002 at 1:00 p.m. ET
2) Live via conference call by dialing (800) 289-0496 at 4:30 p.m. ET. A replay of the call will be available through February 28, 2002 by dialing (888) 203-1112.

If you have any questions, please call VCA Antech's Investor Relations Department at (310) 571-6505. VCA Antech, Inc. (NASDAQ: WOOF), headquartered in Los Angeles, California, is a leading animal health care services company and operates the largest networks of veterinary diagnostic laboratories and free-standing, full-service animal hospitals in the United States. The VCA Antech laboratory network serves all 50 states and provides diagnostic testing for an estimated 13,000 animal hospitals. Its network of animal hospitals offers a full range of services for companion animals, as well as specialized treatments including internal medicine, oncology, ophthalmology and cardiology. For more information visit http://investor.vcaantech.com.